Clinical Trial: Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06991712) titled 'Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients' on May 16.

Brief Summary: The goal of this clinical trial is to determine whether oral supplementation with different nicotinamide adenine dinucleotide (NAD) precursors can improve visual function in adults with primary open-angle glaucoma. The main questions it aims to answer are:

1. Does daily oral administration of equimolar doses of nicotinamide riboside (NR), nicotinamide (NAM), nicotinamide mononucleotide (NMN), or nicotinic acid (NA) improve visual field sensitivity in glaucoma patients over the short term?

2. How do plasma NAD+ metabolite profiles chan...